Sarda Proteins Ltd (BOM:519242)

Sarda Proteins Statistics

Total Valuation

Sarda Proteins has a market cap or net worth of INR 796.16 million. The enterprise value is 722.62 million.

Market Cap	796.16M
Enterprise Value	722.62M

Important Dates

The next estimated earnings date is Friday, May 22, 2026.

Earnings Date	May 22, 2026
Ex-Dividend Date	n/a

Share Statistics

Sarda Proteins has 8.98 million shares outstanding. The number of shares has decreased by -0.11% in one year.

Current Share Class	8.98M
Shares Outstanding	8.98M
Shares Change (YoY)	-0.11%
Shares Change (QoQ)	-0.72%
Owned by Insiders (%)	6.05%
Owned by Institutions (%)	0.40%
Float	1.43M

Valuation Ratios

The trailing PE ratio is 23.97.

PE Ratio	23.97
Forward PE	n/a
PS Ratio	4.93
PB Ratio	26.40
P/TBV Ratio	26.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	113.28
EV / Sales	4.47
EV / EBITDA	249.18
EV / EBIT	249.61
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.03, with a Debt / Equity ratio of 0.05.

Current Ratio	1.03
Quick Ratio	0.14
Debt / Equity	0.05
Debt / EBITDA	0.53
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 23.65% and return on invested capital (ROIC) is 6.52%.

Return on Equity (ROE)	23.65%
Return on Assets (ROA)	0.41%
Return on Invested Capital (ROIC)	6.52%
Return on Capital Employed (ROCE)	9.60%
Weighted Average Cost of Capital (WACC)	-9.68%
Revenue Per Employee	80.79M
Profits Per Employee	3.19M
Employee Count	2
Asset Turnover	0.36
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -32.28% in the last 52 weeks. The beta is -2.54, so Sarda Proteins's price volatility has been lower than the market average.

Beta (5Y)	-2.54
52-Week Price Change	-32.28%
50-Day Moving Average	75.38
200-Day Moving Average	79.99
Relative Strength Index (RSI)	69.17
Average Volume (20 Days)	1,338

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sarda Proteins had revenue of INR 161.58 million and earned 6.38 million in profits. Earnings per share was 3.70.

Revenue	161.58M
Gross Profit	6.80M
Operating Income	2.90M
Pretax Income	6.38M
Net Income	6.38M
EBITDA	2.90M
EBIT	2.90M
Earnings Per Share (EPS)	3.70

Balance Sheet

The company has 75.10 million in cash and 1.55 million in debt, with a net cash position of 73.55 million or 8.19 per share.

Cash & Cash Equivalents	75.10M
Total Debt	1.55M
Net Cash	73.55M
Net Cash Per Share	8.19
Equity (Book Value)	30.16M
Book Value Per Share	17.49
Working Capital	28.86M

Cash Flow

Operating Cash Flow	-763.89M
Capital Expenditures	n/a
Depreciation & Amortization	5,000
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 4.21%, with operating and profit margins of 1.79% and 3.95%.

Gross Margin	4.21%
Operating Margin	1.79%
Pretax Margin	3.95%
Profit Margin	3.95%
EBITDA Margin	1.79%
EBIT Margin	1.79%
FCF Margin	n/a

Dividends & Yields

Sarda Proteins does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.11%
Shareholder Yield	0.11%
Earnings Yield	0.80%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Sarda Proteins has an Altman Z-Score of 0.39 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.39
Piotroski F-Score	3